<DOC>
	<DOCNO>NCT02675374</DOCNO>
	<brief_summary>This single-institution randomize control trial prospective enrol 48 patient schedule aortic valve replacement . The objective present investigation determine role Polaramine® reduce hemodynamic instability separation cardiopulmonary bypass ( CPB ) cardiac surgery . Our hypothesis Polaramine® play important role reduce dysfunction autonomic nervous system hemodynamic stability separation CPB .</brief_summary>
	<brief_title>Hemodynamic Instability Prevented With Polaramine® Infusion Before Extracorporeal Circulation</brief_title>
	<detailed_description>Vasoplegic syndrome recognize common complication CPB . Its incidence range 5 % 25 % cardiac surgery require CPB . Such syndrome relate inflammatory reaction , attribute CPB . This syndrome typically characterized combination different parameter low specificity sensitivity , low systemic vascular resistance lead hypotension impose perfusion vasopressor high normal cardiac output . Investigators preliminary data suggest vasoplegic syndrome might relate heart manipulation surgery . Tearing maneuver perform heart chamber trigger peaks pressure stimulating , consequently , baroreceptor finally result arteriovenous vasodilation via neurogenic endogenous pathway . According investigator initial investigation , reaction appear relate basophil degranulation release vasoactive substance . The hypothesis present trial reduction basophils degranulation release vasoactive substance via antihistaminic could lower incidence vasoplegic syndrome . This study aim determine effect antihistamine ( dexchlorpheniramine ( Polaramine® ) ) administer intravenously CPB , vasoplegic syndrome incidence separation CPB .</detailed_description>
	<mesh_term>Vasoplegia</mesh_term>
	<mesh_term>Dexchlorpheniramine</mesh_term>
	<mesh_term>Chlorpheniramine</mesh_term>
	<criteria>Men age 18 old Post menopausal woman Patients schedule aortic valve replacement traditional sternotomy CPB Patients leave ventricular ejection fraction lower 40 % Patients pulmonary arterial hypertension high 50mm Hg , Redo cardiac surgery , Atrioventricular intraventricular conduction disturbance Epilepsy convulsion Atopic disease Women childbearing potential Patients risk glaucoma Patients therapy interact dexchlorpheniramine ( Polaramine® ) . Patients unable provide sign informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Cardiac surgery</keyword>
	<keyword>cardiopulmonary bypass</keyword>
	<keyword>dexchlorpheniramine</keyword>
	<keyword>H1 blocker</keyword>
	<keyword>norepinephrine</keyword>
	<keyword>histamine release</keyword>
</DOC>